No abstract available
MeSH terms
-
Animals
-
Brain Ischemia / drug therapy
-
Brain Ischemia / physiopathology
-
Clinical Trials, Phase II as Topic
-
Disease Models, Animal
-
Erythropoietin / administration & dosage
-
Erythropoietin / adverse effects
-
Erythropoietin / therapeutic use*
-
Humans
-
Neuroprotective Agents / administration & dosage
-
Neuroprotective Agents / adverse effects
-
Neuroprotective Agents / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / therapeutic use
-
Subarachnoid Hemorrhage / drug therapy*
-
Subarachnoid Hemorrhage / physiopathology
-
Time Factors
Substances
-
Neuroprotective Agents
-
Recombinant Proteins
-
Erythropoietin